Government multi super speciality hospital rolls out affordable screening for cancer
According to a press release, the centre, which was inaugurated on June 8, 2018, offers four types of packages - Gold, Diamond, Platinum and Platinum Plus at a cost of Rs. 1,000, Rs. 2,000, Rs. 3,000 and Rs. 4,000 respectively. Complete blood count, blood sugar, urine analysis, lipid profile, Liver Function Test, Renal Function Test, Thyroid Function Test, bone profile, ECG, ECHO, X-Ray, ultrasound, Dexa scan, eye test, treadmill test and lung function test are being carried out. So far, more than 75,000 persons have been screened at the centre.
With the incidence of cancers on the increase, the centre has launched a 'Titanium' package to screen for tumour markers. TNGMSSH's director R. Mani launched the new package on July 23. By conducting a simple blood test, occult tumours can be detected in its early stages before symptoms appear. The package costing Rs. 2,500 can detect more than 10 types of cancers at an early stage. In private laboratories, the tests would cost around Rs. 20,000 to Rs. 25,000, the release said.
Titanium cancer screening package includes blood tests for tumour markers such as Prostate Specific Antigen for prostate cancer, CA 125 for cancer of the ovary, CA 19.9 for cancer of the pancreas, Alpha Feto Protein for cancer of the liver, thyroglobulin for cancer of the thyroid along with pap smear for cervical cancer and mammogram for breast cancer. An oral examination and doctor consultation is also included. An ENT specialist has been appointed for oral and laryngeal screening.
In case a person requires a follow-up test after a few months, the centre has customised the cancer screening tests in a way that the required test alone can be done, doctors said.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Economic Times
9 minutes ago
- Economic Times
Stock Radar: Syngene International showing signs of momentum after falling 26% from highs; what should investors do?
Syngene International Ltd, a player in the healthcare space, has gained momentum over the past month, helping the stock reclaim key moving averages — a sign that the bulls are trying to take traders with a high-risk profile can look to buy the stock for a target of Rs 761-846 in the next couple of months, suggest stock hit a high of Rs 960 on December 2, 2024, but it failed to hold the momentum. It closed at Rs
Time of India
3 hours ago
- Time of India
Prostate health in focus as BPH drug demand rises in Gujarat
Ahmedabad: The sale of drugs used to treat benign prostatic hyperplasia (BPH)—a non-cancerous enlargement of the prostate gland—has surged by 70% over the past four years, indicating a significant rise in cases across the state. According to data from Pharmarack, the moving annual total (MAT) for BPH drugs was Rs 55.24 crore in June 2021, which rose to Rs 93.93 crore in June this year. The MAT for the overall urology segment also saw a 42% increase, from Rs 115.22 crore to Rs 164.2 crore during the same period. You Can Also Check: Ahmedabad AQI | Weather in Ahmedabad | Bank Holidays in Ahmedabad | Public Holidays in Ahmedabad "BPH affects a significant portion of men aged 50 and above, causing urinary difficulties and impacting quality of life. While the condition has always existed, the sharp rise in diagnosed cases and medical interventions reflects broader trends," said a pharmaceutical distributor who requested anonymity. Industry sources said that pharma companies have improved drug delivery through fixed-dose combinations, leading to better patient compliance and outcomes. The most common prescriptions now include alpha-blockers and 5-alpha-reductase inhibitors, which help alleviate symptoms and slow further prostate growth, Pharmarack data indicated. According to urologists in Ahmedabad, men are increasingly addressing symptoms of an enlarged prostate rather than ignoring them. The stigma around men's urological health is gradually diminishing, especially in urban and semi-urban areas. Dr Rohit Bhattar, a uro-onco surgeon at a city-based private hospital, said, "There has been a significant rise in BPH cases over the past decade. While traditionally considered a disease of old age, we are now seeing some patients even under the age of 50, often due to other health conditions and lifestyle factors. Greater awareness today also plays a role compared to a decade ago." While metros and Tier-I cities initially drove demand for BPH drugs, pharmaceutical industry sources report that Tier-II cities and rural areas are now seeing growing traction. Dr Hemang Bakshi, another uro-onco surgeon, noted, "The rise in drug sales must be viewed in the context of increased life expectancy. Medications are often prescribed to maintain or enhance prostate function over time. Since onset typically occurs around the age of 60, patients may remain on treatment for several years. This extended treatment duration is a contributing factor. We've certainly seen a decadal rise in the incidence of the condition. " Experts say improvements in healthcare access and preventive diagnostics in Gujarat have made a noticeable impact. Routine check-ups, ultrasounds, and PSA tests are increasingly being used to detect prostate issues at earlier stages.
Time of India
4 hours ago
- Time of India
6 PHED engrs served notice over 150 crore tubewell scam in Jalore
Jaipur: Public health engineering department (PHED) has issued notices to six engineers of the department, including a retired engineer, for alleged involvement in a scam of Rs 150 crore. Officials said these engineers reportedly gave Operations and Maintenance (O&M) tenders to two firms for more than 900 tubewells in Jalore district when they were entitled to O&M of only 20 tubewells. "We took up the issue with PHED minister Kanhaiya Lal Choudhary. Following his instructions, we are going to take major steps against these accused engineers. We will also lodge complaints with police in this regard," disclosed a senior PHED official Wednesday. An official of the department claimed that the accused—then executive engineers Umesh Kumar Meena, Shyam Bihari Bairwa, Jitendra Trivedi, Hemant Kumar Bairwa, Ashish Dwivedi (retd), and Hemant Kumar Vaishnav—gave the work orders for O&M of 981 tubewells on Aug 12, 2022, to two firms—MM Construction and MS Raj Enterprise. "In gross violation of norms, the then superintendent engineer of the circle issued this work order for 981 tubewells. The two firms should have got work orders for only 20 tubewells. For the last three years, the department is unnecessarily wasting money on O&M expenditure for such a huge number of additional tubewells. The department has also blacklisted the two firms," the official added. Investigation revealed that PHED bore O&M expenditure for around 3,500 tubewells in Jalore for the last three years, when the actual number of tubewells of the department in the district was only close to 1,500.
